5Katlloii RE, Couri DM. left ventricular hypertrophy:major risk factor in patients with hypertension, update and practi- cal clinical applications [ J ]. Int hypertension, 2011, 187(6) :1 - 10.
6Beltman FW, Heesen WF, Smit A J, et al. Effects of amlodip- ine and lisinopril on left ventricular mass and diastolic func- tion in previously untreated patients with mild to moderate diastolic hypertension[ J]. Blood press, 1998,7 ( 2 ) : 109 -117.
7Terpstra WF1, May JF, Smit A J, et al. Long-term effects of amlodipine and lisinopril on left ventricular mass and dias- tolic function in elderly, previously untreated hypertensive patients : the ELVERA trial [ J]. J Hypertens ,2001,19 (2) : 303 - 309.
8Kannel WB. Left ventricular hypertrophy as a risk factor:the Framingham experience [ J ]. J Hypertens-suppl, 1991, 9(2) :3-S.
